UT Southwestern and Komen Foundation Offer Breast Care Fellowship

Publication
Article
OncologyONCOLOGY Vol 12 No 8
Volume 12
Issue 8

The Center for Breast Care at UT Southwestern Medical Center in Dallas and the Susan G. Komen Breast Cancer Foundation have teamed up to offer a new 1-year fellowship for physicians interested in the multidisciplinary care of breast

The Center for Breast Care at UT Southwestern Medical Center in Dallas and the Susan G. Komen Breast Cancer Foundation have teamed up to offer a new 1-year fellowship for physicians interested in the multidisciplinary care of breast cancer patients.

This program was designed to provide the physician with an in-depth understanding of the entire scope of a breast-cancer patient’s treatment. It places special emphasis on refining physicians’ skills in counseling and discussing such topics as quality-of-life and end-of-life issues.

Treating the Whole Patient

"We are delighted to join the Komen Foundation and offer a fellowship that specifically addresses the needs of physicians in treating breast cancer patients comprehensively," said Dr. George Peters, executive director of the Center for Breast Care and holder of the

Marilyn R. Corrigan Distinguished Chair in Breast Cancer Surgery. "This fellowship has the potential to set a new standard for multidisciplinary breast care," said Elda Railey, director of national grants. "Through this program, the fellows will broaden their understanding of all the treatment issues faced by breast cancer patients. The program also provides education in genetics and the disease’s effects on a patient’s daily life and family. It is a comprehensive approach to training in today’s world of specialization."

Fellows will be instructed in pathology, plastic surgery, and medical oncology, radiation oncology, radiology, surgery, genetics, and psychiatry/psychology at UT Southwestern. They will also spend 1 day a month at the Komen Foundation headquarters developing their communication skills. Successful candidates must hold an md or equivalent degree and be board-eligible or board-certified in one of the above areas.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer. Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer.
ADCs demonstrate superior efficacy vs chemotherapy but maintain a similar efficacy profile that requires multidisciplinary collaboration to optimally treat.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Related Content